Structural Requirements for Functional Interaction of Glutathione Tripeptide Analogs with the Human Multidrug Resistance Protein 1 (MRP1)
- 1 February 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 304 (2) , 643-653
- https://doi.org/10.1124/jpet.102.044073
Abstract
The human multidrug resistance protein 1 (MRP1) is a primary active transporter of reduced (GSH) and oxidized glutathione, as well as GSH-, glucuronate-, and sulfate-conjugated organic anions. In addition, the transport of certain MRP1 substrates is stimulated by the presence of GSH. To evaluate the structural features of GSH required for interaction with the protein, we investigated the ability of a series of GSH analogs to enhance GSH stimulatable transport of [(3)H]estrone 3-sulfate (E(1)SO(4)). We found that substitution of the gamma-Glu residue with Gly, beta-Asp, and alpha-Glu resulted in complete loss of transport stimulation. In contrast, substitution of Gly with Glu or beta-Ala resulted in only a partial loss of stimulatory activity. E(1)SO(4) transport activity surpassed GSH-stimulated levels in the presence of tripeptides in which Cys was substituted with the hydrophobic amino acids Leu, Phe, and homo-Phe. Moreover, polar substitutions of Cys did not enhance transport to the same extent as nonpolar substitutions of comparable size. gamma-Glu-Leu-Gly was 1.6-fold more effective than GSH in stimulating E(1)SO(4) uptake, and kinetic analysis indicated this was due to an increased V(max). In addition, this tripeptide was shown to be a competitive inhibitor of apigenin-stimulated GSH transport (K(i) value of 14 microM), confirming that it either interacts with the same site on MRP1 as GSH or that the binding of the two tripeptides is mutually exclusive. These data provide insight into the architecture of the GSH binding domain of MRP1.This publication has 35 references indexed in Scilit:
- A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistancePharmacogenetics, 2002
- Role of the Glutamyl α-Carboxylate of the Substrate Glutathione in the Catalytic Mechanism of Human Glutathione Transferase A1-1Biochemistry, 2001
- Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutesJournal of Hepatology, 2001
- A Family of Drug Transporters: the Multidrug Resistance-Associated ProteinsJNCI Journal of the National Cancer Institute, 2000
- Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione exportBritish Journal of Cancer, 2000
- Cation-π interactions in structural biologyProceedings of the National Academy of Sciences, 1999
- Effects of Chronic Ethacrynic Acid Exposure on Glutathione Conjugation and MRP Expression in Human Colon Tumor CellsBiochemical and Biophysical Research Communications, 1996
- X‐ray crystal structures of cytosolic glutathione S‐transferasesEuropean Journal of Biochemistry, 1994
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- The glutathione-binding site in glutathione S-transferases. Investigation of the cysteinyl, glycyl and γ-glutamyl domainsBiochemical Journal, 1990